SGP Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

32.440

Open

24.000

VWAP

26.33

Vol

1.20M

Mkt Cap

842.45M

Low

20.160

Amount

31.48M

EV/EBITDA(TTM)

Total Shares

31.91M

EV/OCF(TTM)

P/S(TTM)

SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.

Events Timeline

(ET)

2026-02-06

12:20:00

SpyGlass Pharma Prices 9.375M Shares at $16.00

2026-02-06

12:00:00

SpyGlass Pharma Prices 9.375M Shares at $16.00

News

8.5

02-06moomoo

PinnedSPYGLASS PHARMA INC SETS IPO PRICE AT $16.00 PER SHARE

8.5

02-06Barron's

Jennifer Garner's Once Upon a Farm Sees Nearly 20% Increase as IPO Week Concludes

8.5

02-06seekingalpha

SpyGlass Pharma and Agomab's Contrasting Nasdaq Debuts

8.5

02-06seekingalpha

SpyGlass Pharma and Agomab IPO Pricing Announced

8.5

02-06renaissancecapital

SpyGlass Pharma Raises $150 Million in IPO for Eye Condition Treatments

8.5

02-06renaissancecapital

SpyGlass Pharma Raises $150 Million in IPO for Eye Condition Treatments

0 Analyst Rating

Wall Street analysts forecast SGP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGP is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for SpyGlass Pharma Inc (SGP.O) is , compared to its 5-year average forward P/E of . For a more detailed relative valuation and DCF analysis to assess SpyGlass Pharma Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

Current PE

NaN

Overvalued PE

Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

Current EV/EBITDA

NaN

Overvalued EV/EBITDA

Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

Current PS

NaN

Overvalued PS

Undervalued PS

Financials

AI Analysis

Annual

Quarterly

Whales Holding SGP

Trading Trends

People Also Watch

Frequently Asked Questions

What is SpyGlass Pharma Inc (SGP) stock price today?

The current price of SGP is 26.4 USD — it has increased 65 % in the last trading day.

What is SpyGlass Pharma Inc (SGP)'s business?

What is the price predicton of SGP Stock?

Wall Street analysts forecast SGP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGP is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SpyGlass Pharma Inc (SGP)'s revenue for the last quarter?

SpyGlass Pharma Inc revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is SpyGlass Pharma Inc (SGP)'s earnings per share (EPS) for the last quarter?

SpyGlass Pharma Inc. EPS for the last quarter amounts to USD, decreased % YoY.

How many employees does SpyGlass Pharma Inc (SGP). have?

SpyGlass Pharma Inc (SGP) has 0 emplpoyees as of February 08 2026.

What is SpyGlass Pharma Inc (SGP) market cap?

Today SGP has the market capitalization of 842.45M USD.

SGP Overview

SGP Overview

Events Timeline

News

No data

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding SGP

Trading Trends

People Also Watch

Frequently Asked Questions

What is SpyGlass Pharma Inc (SGP) stock price today?

What is SpyGlass Pharma Inc (SGP)'s business?

What is the price predicton of SGP Stock?

What is SpyGlass Pharma Inc (SGP)'s revenue for the last quarter?

What is SpyGlass Pharma Inc (SGP)'s earnings per share (EPS) for the last quarter?

How many employees does SpyGlass Pharma Inc (SGP). have?

What is SpyGlass Pharma Inc (SGP) market cap?